HSTM.NASDAQHealthstream INC

Form 4: HealthStream Director Linda Rebrovick Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Director Linda Rebrovick reports the vesting of restricted share units and subsequent acquisition of common stock in HealthStream Inc.

Summary

  • Linda Rebrovick, a director of HealthStream Inc. (HSTM), filed a Form 4 on March 25, 2024, reporting changes in beneficial ownership of the company's stock.
  • The report details the vesting of restricted share units (RSUs) and the subsequent acquisition of common stock.
  • Specifically, 2,092 shares of common stock were acquired upon the vesting of RSUs.
  • Following these transactions, Rebrovick directly owns 53,775 shares of HealthStream Inc.
  • Additionally, Rebrovick holds 1,149 restricted share units.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of insider transactions related to equity compensation. There's no indication of positive or negative news about the company's performance.

Positives

  • The vesting of RSUs indicates that performance or time-based milestones have been met.
  • The director's continued holding of a significant number of shares (53,775) suggests confidence in the company's future.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure related to insider transactions and doesn't provide specific insights into broader industry trends. However, it reflects the standard practice of compensating executives and directors with equity-based awards in the healthcare technology sector.

Comparison to Industry Standards

  • Equity compensation, including RSUs, is a common practice among publicly traded companies, especially in the technology and healthcare sectors.
  • Companies like Cerner (now Oracle Health) and Allscripts also utilize RSUs as part of their compensation packages for directors and executives.
  • The vesting schedules (three-year vesting with annual installments) are fairly standard in the industry.

Stakeholder Impact

  • The transaction has a minor positive impact on shareholders as it aligns the director's interests with those of the shareholders.
  • The vesting of RSUs does not have a significant impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
03/17/2022Start date for annual vesting of some restricted share units over three years.
03/23/2023Start date for annual vesting of other restricted share units over three years.
03/25/2024Date of transaction and filing of Form 4, reporting the vesting of RSUs and acquisition of common stock.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.